dc.contributor.author
Dzietko, Mark
dc.contributor.author
Hahnemann, Maria
dc.contributor.author
Polley, Oliver
dc.contributor.author
Sifringer, Marco
dc.contributor.author
Felderhoff-Mueser, Ursula
dc.contributor.author
Bührer, Christoph
dc.date.accessioned
2018-06-08T04:20:32Z
dc.date.available
2015-05-11T11:09:58.927Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/17088
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-21268
dc.description.abstract
Perinatal infections have a negative impact on brain development. However, the
underlying mechanisms leading to neurological impairment are not completely
understood and reliable models of inflammation are urgently needed. Using
phorbol-myristate-acetate as an activator of inflammation, we investigated the
effect on the developing rodent brain. Neonatal rats and mice deficient in
IL-18 or IRAK-4 were exposed to PMA. Brains were assessed for regulation of
pro- and anti-inflammatory cytokines and cell death 24 hrs, 7 and 14 days
after treatment. PMA induced an inflammatory response and caused widespread
neurodegeneration in the brains of 3- and 7-day-old rats. In contrast, 14-day-
old rats were resistant to the neurotoxic effect of PMA. Histological
evaluation at the age of 14 and 21 days revealed a destruction of the cortical
microstructure with decreased numerical density of neuronal cells. Mice
deficient in IL-18 or IRAK-4 were protected against PMA induced brain injury.
PMA treatment during a vulnerable period can alter brain development. IL-18
and IRAK-4 appear to be important for the development of PMA induced injury.
en
dc.rights.uri
http://creativecommons.org/licenses/by/3.0/
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit
dc.title
Effects of PMA (PHORBOL-12-MYRISTATE-13-ACETATE) on the Developing Rodent
Brain
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation
BioMed Research International. - 2015 (2015), Artikel Nr. 318306
dcterms.bibliographicCitation.doi
10.1155/2015/318306
dcterms.bibliographicCitation.url
http://dx.doi.org/10.1155/2015/318306
refubium.affiliation
Charité - Universitätsmedizin Berlin
de
refubium.mycore.fudocsId
FUDOCS_document_000000022403
refubium.note.author
Der Artikel wurde in einer Open-Access-Zeitschrift publiziert.
refubium.resourceType.isindependentpub
no
refubium.mycore.derivateId
FUDOCS_derivate_000000004892
dcterms.accessRights.openaire
open access